Cargando…

Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada

BACKGROUND: Hypertensive disorders of pregnancy (HDP) are associated with an increased risk of premature cardiovascular disease (CVD), but existing cardiovascular prediction models do not adequately capture risks in young women. We developed a model to predict the 10‐year risk of premature CVD and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukah, U. Vivian, Dayan, Natalie, Auger, Nathalie, He, Siyi, Platt, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763374/
https://www.ncbi.nlm.nih.gov/pubmed/33054502
http://dx.doi.org/10.1161/JAHA.120.017328
_version_ 1783628003336519680
author Ukah, U. Vivian
Dayan, Natalie
Auger, Nathalie
He, Siyi
Platt, Robert W.
author_facet Ukah, U. Vivian
Dayan, Natalie
Auger, Nathalie
He, Siyi
Platt, Robert W.
author_sort Ukah, U. Vivian
collection PubMed
description BACKGROUND: Hypertensive disorders of pregnancy (HDP) are associated with an increased risk of premature cardiovascular disease (CVD), but existing cardiovascular prediction models do not adequately capture risks in young women. We developed a model to predict the 10‐year risk of premature CVD and mortality among women who have HDP. METHODS AND RESULTS: Using a population‐based cohort of women with HDP who delivered between April 1989 and March 2017 in Quebec, Canada, we developed a 10‐year CVD risk model using Cox proportional hazards regression. Women aged 18 to 45 years were followed from their first HDP‐complicated delivery until March 2018. We assessed performance of the model based on discrimination, calibration, and risk stratification ability. Internal validity was assessed using the bootstrap method. The cohort included 95 537 women who contributed 1 401 084 person‐years follow‐up. In total, 4024 (4.2%) of women were hospitalized for CVD, of which 1585 events (1.6%) occurred within 10 years of follow‐up. The final model had modest discriminatory performance (area under the receiver operating characteristic curve, 0.66; 95% CI, 0.65–0.67) and good calibration with slope of 0.95 and intercept of −0.19. There was moderate classification accuracy (likelihood ratio+: 5.90; 95% CI, 5.01–6.95) in the highest‐risk group upon risk stratification. CONCLUSIONS: Overall, our model had modest performance in predicting the 10‐year risk of premature CVD for women with HDP. We recommend the addition of clinical variables, and external validation, before consideration for clinical use.
format Online
Article
Text
id pubmed-7763374
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77633742020-12-28 Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada Ukah, U. Vivian Dayan, Natalie Auger, Nathalie He, Siyi Platt, Robert W. J Am Heart Assoc Original Research BACKGROUND: Hypertensive disorders of pregnancy (HDP) are associated with an increased risk of premature cardiovascular disease (CVD), but existing cardiovascular prediction models do not adequately capture risks in young women. We developed a model to predict the 10‐year risk of premature CVD and mortality among women who have HDP. METHODS AND RESULTS: Using a population‐based cohort of women with HDP who delivered between April 1989 and March 2017 in Quebec, Canada, we developed a 10‐year CVD risk model using Cox proportional hazards regression. Women aged 18 to 45 years were followed from their first HDP‐complicated delivery until March 2018. We assessed performance of the model based on discrimination, calibration, and risk stratification ability. Internal validity was assessed using the bootstrap method. The cohort included 95 537 women who contributed 1 401 084 person‐years follow‐up. In total, 4024 (4.2%) of women were hospitalized for CVD, of which 1585 events (1.6%) occurred within 10 years of follow‐up. The final model had modest discriminatory performance (area under the receiver operating characteristic curve, 0.66; 95% CI, 0.65–0.67) and good calibration with slope of 0.95 and intercept of −0.19. There was moderate classification accuracy (likelihood ratio+: 5.90; 95% CI, 5.01–6.95) in the highest‐risk group upon risk stratification. CONCLUSIONS: Overall, our model had modest performance in predicting the 10‐year risk of premature CVD for women with HDP. We recommend the addition of clinical variables, and external validation, before consideration for clinical use. John Wiley and Sons Inc. 2020-10-15 /pmc/articles/PMC7763374/ /pubmed/33054502 http://dx.doi.org/10.1161/JAHA.120.017328 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Ukah, U. Vivian
Dayan, Natalie
Auger, Nathalie
He, Siyi
Platt, Robert W.
Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada
title Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada
title_full Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada
title_fullStr Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada
title_full_unstemmed Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada
title_short Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population‐Based Study in Quebec, Canada
title_sort development and internal validation of a model predicting premature cardiovascular disease among women with hypertensive disorders of pregnancy: a population‐based study in quebec, canada
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763374/
https://www.ncbi.nlm.nih.gov/pubmed/33054502
http://dx.doi.org/10.1161/JAHA.120.017328
work_keys_str_mv AT ukahuvivian developmentandinternalvalidationofamodelpredictingprematurecardiovasculardiseaseamongwomenwithhypertensivedisordersofpregnancyapopulationbasedstudyinquebeccanada
AT dayannatalie developmentandinternalvalidationofamodelpredictingprematurecardiovasculardiseaseamongwomenwithhypertensivedisordersofpregnancyapopulationbasedstudyinquebeccanada
AT augernathalie developmentandinternalvalidationofamodelpredictingprematurecardiovasculardiseaseamongwomenwithhypertensivedisordersofpregnancyapopulationbasedstudyinquebeccanada
AT hesiyi developmentandinternalvalidationofamodelpredictingprematurecardiovasculardiseaseamongwomenwithhypertensivedisordersofpregnancyapopulationbasedstudyinquebeccanada
AT plattrobertw developmentandinternalvalidationofamodelpredictingprematurecardiovasculardiseaseamongwomenwithhypertensivedisordersofpregnancyapopulationbasedstudyinquebeccanada